Randomized Comparison of the Immunogenicity of Recombinant and Egg-based Influenza Vaccines Among Healthcare Personnel in Israel
Latest Information Update: 21 Nov 2023
At a glance
- Drugs Influenza virus RIV4 vaccine-(FluBlok Quadrivalent) (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 05 Oct 2022 Status changed from active, no longer recruiting to completed.
- 04 Aug 2021 Planned End Date changed from 30 Aug 2020 to 30 Aug 2022.
- 26 Aug 2020 New trial record